S1PR3 and fatty liver disease: The exacerbated hepatic steatosis and inflammation observed in HFD-fed S1PR3−/− mice above what was observed for HFD-fed WT mice suggests that S1P-S1PR3 signalling confers protection from lipid accumulation and inflammation in the liver.